Clinical trial
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry &…
NCT00358943 · Genzyme, a Sanofi Company, Industry · Recruiting
Key facts
| NCT number | NCT00358943 |
|---|---|
| Title | International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry |
| Official title | Gaucher Disease Registry Protocol |
| Lead sponsor | Genzyme, a Sanofi Company, Industry |
| Status | Recruiting |
| Study type | Observational [Patient Registry] |
| Conditions | Gaucher Disease, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease, Glucosylceramide Beta-Glucosidase Deficiency Disease |
| Enrollment | 12,000 |
| Start date | Apr 1, 1991 |
| Primary completion | Jan 31, 2034 |
| Completion | Jan 31, 2034 |
| First posted | Aug 1, 2006 |
| Last update posted | Jan 6, 2026 |
| Countries | Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, China, Colombia, Croatia, Czechia, Denmark, Dominican Republic and 40 more |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: